Direct Thrombin Inhibitor [EPC]

992 reported adverse events

Drugs of this class: ARGATROBAN

These side effects are most commonly reported by patients taking drugs of the Direct Thrombin Inhibitor [EPC] class:

# Side effect Count
0 HEPARIN-INDUCED THROMBOCYTOPENIA 106
1 INTERNATIONAL NORMALISED RATIO INCREASED 106
2 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 80
3 COAGULATION TIME PROLONGED 63
4 HAEMORRHAGE 60
5 CEREBRAL INFARCTION 49
6 PULMONARY EMBOLISM 46
7 DEEP VEIN THROMBOSIS 43
8 THROMBOSIS 42
9 THROMBOCYTOPENIA 40
See all common reactions for Direct Thrombin Inhibitor [EPC]

Drugs of the Direct Thrombin Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BURKITT'S LYMPHOMA STAGE IV 1 0.2500
1 GRANULICATELLA BACTERAEMIA 1 0.2000
2 OESOPHAGEAL INTRAMURAL HAEMATOMA 7 0.1842
3 FAECAL CALPROTECTIN DECREASED 2 0.1667
4 VERTEBRAL ARTERY ANEURYSM 1 0.1250
5 BILE OUTPUT 1 0.1250
6 MYOCARDITIS MYCOTIC 1 0.0714
7 LYMPHOCYTE STIMULATION TEST NEGATIVE 1 0.0625
8 GASTRIC LAVAGE ABNORMAL 1 0.0588
9 COAGULATION TIME PROLONGED 63 0.0555
See all enriched reactions for Direct Thrombin Inhibitor [EPC]